Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Quetiapine XR in Healthy Volunteers
NCT03317236Phase 4Completed
- Sponsor
- Laboratorio Elea Phoenix S.A.
- Start
- Mar 2017
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of quetiapine in schizophrenia, bipolar disorder (BD), sponsored by Laboratorio Elea Phoenix S.A.. Started Mar 2017; status: completed.
02
Drugs
quetiapine
03
Conditions
schizophreniabipolar disorder (BD)
Beyond the preview
Go deeper on NCT03317236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03317236.